The study demonstrates that the METTL3-IGF2BP3 axis enhances ID1 mRNA stability in osteosarcoma, suggesting a potential therapeutic target.
The METTL3-IGF2BP3 axis facilitates OS progression by enhancing ID1 mRNA stability and expression, highlighting its potential as a therapeutic target.
No takes yet. Share an insight, caveat, or question.
Shu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: